A Los Angeles Times columnist is sounding off against efforts to repeal the 2.3% medical device industry tax, calling manufacturers' ongoing lobbying campaign to undo the measure a "narrow-minded and dishonest" campaign. Passed to help fund part of the Affordable Care Act, the tax kicked in on Jan. 1, 2013 and is designed to raise $30 billion over the next decade. Michael Hiltzik writes that the tax is necessary, will help the greater health reform law succeed, and needs to stay put. He argues that a handful of giant firms will field most of the cost, and he questions the validity of studies that outline how the tax will harm the industry. Additionally, he faults the industry and other tax opponents for not coming up with an alternative to the tax that would raise the revenue lost if it is repealed. Column